2/7/2018 | CV | Priceline opts to settle conversions of notes due March 2018 in cash
|
1/23/2018 | CV | Market Commentary: Teekay eyes deal; Insmed seen as cheap; new paper active; Priceline gains on new CFO
|
11/7/2017 | CV | Market Commentary: Apollo add-on active in trading, Insulet deal upsized, Sarepta Therapeutics plans new deal
|
10/23/2017 | CV | Market Commentary: Walter Investment trades at new low on reorganization news; primary market remains quiet
|
10/17/2017 | CV | Market Commentary: Impax Laboratories jumps in active trade after merger news; Herbalife slips; Cemex up
|
8/10/2017 | CV | Market Commentary: Resource Capital plans new issue; Heritage a no-show; BioMarin’s recent deal remains in play
|
8/10/2017 | BKCVIG | Moody’s assigns Baa1 to Priceline notes
|
8/10/2017 | BKCVIG | S&P assigns BBB+ to Priceline notes
|
8/9/2017 | CV | Market Commentary: Radius Health prices, dips below issue price; BioMarin busy; Priceline falters post-earnings
|
7/18/2017 | CV | Market Commentary: Morning Commentary: Bellwether convertible issues in focus; DISH paper declines with stock
|
6/20/2017 | CV | Market Commentary: Energy names sink with drop in oil prices; Tesla edges up; Synaptics, Teladoc notes on tap
|
4/12/2017 | CV | Market Commentary: Convertible bond go-gos like Priceline, Tesla trade; Chesapeake up, but down from day’s highs
|
4/12/2017 | CV | Market Commentary: Morning Commentary: Convertible bond go-gos like Priceline, Tesla trade; Chesapeake gains ground
|
4/11/2017 | CV | Market Commentary: Convertible bond trading muted amid geopolitical issues; Priceline active; GoPro gains ground
|
4/11/2017 | CV | Market Commentary: Morning Commentary: Convertible bond trading muted amid geopolitical issues; Priceline steady
|
3/7/2017 | BKCVIG | Moody’s: Priceline notes Baa1
|
3/7/2017 | BKCVIG | S&P rates Priceline notes BBB+
|
2/28/2017 | CV | Market Commentary: Viavi’s new deal does well on the break; Encore issue lackluster; HCI upsized; calendar eyed
|
2/13/2017 | CV | Market Commentary: Microchip’s new 1.625% issue gains ground; Priceline busy; Golar offers five-year notes
|
2/13/2017 | CV | Market Commentary: Morning Commentary: Microchip’s new 1.625% convertibles gain ground; Priceline active, weaker
|
2/7/2017 | CV | Market Commentary: Convertibles little changed in light volume; FXCM crumbles; Zillow quiet ahead of earnings
|
2/7/2017 | CV | Market Commentary: Morning Commentary: Convertibles little changed in light volume; Zillow see positive tone
|
11/28/2016 | CV | Market Commentary: Morning Commentary: Convertibles steady in post-holiday trading; SINA paper follows market trend
|
11/21/2016 | CV | Market Commentary: Upcoming holiday, short week weigh on convertibles trading; Chesapeake firms on OPEC optimism
|
11/15/2016 | CV | Market Commentary: Peabody Energy, Chesapeake convertibles trade up outright; Priceline busy; Blucora firms
|
11/8/2016 | CV | Market Commentary: Priceline convertibles rise on earnings beat; Depomed misses; Medicines mixed; Iconix steady
|
11/8/2016 | CV | Market Commentary: Morning Commentary: Priceline convertibles rise on earnings beat; Depomed misses; Medicines mixed
|
9/27/2016 | CV | Market Commentary: Array BioPharma surges again in active trade; Great Plains, Goldman Sachs BDC launch deals
|
9/27/2016 | CV | Market Commentary: Morning Commentary: Array BioPharma surges again in active trade; Priceline bonds slip
|
9/8/2016 | CV | Market Commentary: New Insulet in line to better on debut; old Insulet slips; Ctrip.com, Inphi remain firm
|
9/2/2016 | CV | Market Commentary: Convertible volumes thin; pricing ‘a touch better’ after jobs report; j2 Global, Tesla add
|
9/2/2016 | CV | Market Commentary: Morning Commentary: Convertibles trading thin, but pricing ‘a touch better’ after jobs report
|
8/25/2016 | CV | Market Commentary: Intel, Priceline, Liberty/Charter paper muted as equities waver; markets eye Yellen speech
|
8/25/2016 | CV | Market Commentary: Morning Commentary: Muted trade including Intel, Priceline, Liberty/Charter; primary market quiet
|
8/5/2016 | CV | Market Commentary: Rayonier brings upsized sale of convertible preferreds; Priceline rises post-earnings
|
8/5/2016 | CV | Market Commentary: Morning Commentary: Rayonier brings upsized sale of convertible preferreds; Priceline on the rise
|
7/29/2016 | CV | Market Commentary: Priceline convertible better ahead of earnings; Whiting rises as investors digest earnings
|
6/27/2016 | CV | Market Commentary: HeartWare surges on takeover news; convertibles lower in light volume; Brexit in focus
|
6/27/2016 | CV | Market Commentary: Morning Commentary: HeartWare surges on takeover news; convertibles mostly lower on light volume
|
5/18/2016 | BKCVIG | Moody’s assigns Baa1 to Priceline notes
|
5/18/2016 | BKCVIG | S&P rates Priceline notes BBB+
|
5/5/2016 | CV | Market Commentary: Atlas Air flies higher in heavy volume; Tesla Motors lower outright, mixed on swap
|
5/4/2016 | CV | Market Commentary: Priceline tanks on profit warning; Heartware drops on weak earnings; Spirit Realty slips
|
5/4/2016 | CV | Market Commentary: Morning Commentary: Priceline tanks on profit-warning; Spirit Realty slips ahead of earnings report
|
4/25/2016 | CV | Market Commentary: Spirit Realty active at higher levels on the back of S&P upgrade; Lam Research slips
|
4/14/2016 | CV | Market Commentary: Priceline 1% convertibles add with shares; Energy XXI files for bankruptcy; SunEdison up
|
4/14/2016 | CV | Market Commentary: Morning Commentary: Priceline 1% convertibles add with shares; Energy XXI files for bankruptcy
|
2/29/2016 | CV | Market Commentary: Horizon Pharma contracts as shares drop; Priceline adds in line; Newmont expands slightly
|
2/29/2016 | CV | Market Commentary: Morning Commentary: Priceline adds in line; Newmont expands; Horizon contracts as shares drop
|
2/22/2016 | CV | Market Commentary: Morning Commentary: Convertibles rise with stock market; SunEdison steady; Prospect Capital firm
|
2/17/2016 | CV | Market Commentary: Planned Invacare deal looks cheap; Priceline 0.9% convertibles contract with higher shares
|
2/17/2016 | CV | Market Commentary: Morning Commentary: Planned Invacare looks cheap; Priceline 0.9% convertibles contract
|
2/11/2016 | CV | Market Commentary: Convertibles lag after crude oil, equities pare sharp losses; Monster Worldwide plunges
|
2/11/2016 | CV | Market Commentary: Morning Commentary: Priceline, Newmont atop Trace tape as rout in broader markets accelerates
|
2/9/2016 | CV | Market Commentary: Energy tanks with lower oil; Chesapeake extends losses; Priceline, salesforce.com move up
|
2/9/2016 | CV | Market Commentary: Morning Commentary: Priceline, salesforce.com move up in line with shares; Chesapeake quiet
|
1/27/2016 | CV | Market Commentary: SanDisk mostly better as market weighs deal; Priceline lower outright; FOMC statement eyed
|
1/27/2016 | CV | Market Commentary: Morning Commentary: Priceline lower outright; earnings in focus; SanDisk convertibles improve
|
1/19/2016 | CV | Market Commentary: Higher-grade convertibles in focus amid better outright sellers; Newmont Mining holds in
|
1/19/2016 | CV | Market Commentary: Morning Commentary: High-grade convertibles strengthen; Newmont Mining bond adds as shares fall
|
1/13/2016 | CV | Market Commentary: Convertibles weaken amid broad-based sell-off in equities; Twitter, Iconix Brand hold in
|
11/20/2015 | BKCVIG | S&P rates Priceline notes BBB+
|
11/20/2015 | BKCVIG | Moody’s applies Baa1 to Priceline notes
|
11/9/2015 | CV | Market Commentary: Iconix, Horizon Pharma regain ground after steep losses; Priceline 1% expands on swap
|
11/9/2015 | CV | Market Commentary: Morning Commentary: Iconix recouping some losses; Priceline 1% off with stock on disappointing view
|
11/6/2015 | CV | Market Commentary: Iconix Brand collapses on accounting restatements, lowered guidance; HomeAway drops back
|
11/3/2015 | CV | Market Commentary: AMAG Pharmaceuticals tumbles outright on earnings miss; Priceline edges up; Ctrip in line
|
11/3/2015 | CV | Market Commentary: Morning Commentary: Priceline little changed in active trade; Ctrip, Tesla Motors slip outright
|
10/2/2015 | CV | Market Commentary: Convertibles decline on weak jobs report, pare losses by the bell; liquidity constrained
|
10/2/2015 | CV | Market Commentary: Morning Commentary: Market loses ground on weak jobs report; liquidity constrained; Priceline slips
|
9/24/2015 | CV | Market Commentary: Convertibles weaken, outperform high yield; Illumina contracts 0.5 point; Whiting holds in
|
9/8/2015 | CV | Market Commentary: Convertibles see better bidders; Impax up outright with FDA news; Dycom, Stericycle on tap
|
9/8/2015 | CV | Market Commentary: Morning Commentary: Convertibles see better bidders; Impax Labs jumps with positive FDA news
|
9/3/2015 | CV | Market Commentary: Convertibles better on improved sentiment; SanDisk 1.5% gains on swap; SunEdison rises
|
9/3/2015 | CV | Market Commentary: Morning Commentary: Convertibles better on sentiment; SanDisk 1.5% notes up on outright buying
|
8/18/2015 | CV | Market Commentary: New SunEdison convertible preferreds jump; older tranches mixed; Whiting Petroleum slips
|
8/5/2015 | CV | Market Commentary: GNC trades up on debut; Priceline mostly in line after earnings; Chesapeake, Goodrich off
|
8/5/2015 | CV | Market Commentary: Morning Commentary: GNC trades up a little on debut; Priceline bonds mostly in line after earnings
|
7/1/2015 | CV | Market Commentary: Convertibles better bid: SanDisk, Priceline, Intel off their lows; Peabody, Alpha Natural lower
|
7/1/2015 | CV | Market Commentary: Morning Commentary: Peabody Energy in focus after earnings warning; Priceline adds with shares
|
5/7/2015 | CV | Market Commentary: New Anthem adds after upsizing; HeartWare, PHH trade on exchange offers; HeartWare prices
|
5/7/2015 | CV | Market Commentary: Morning Commentary: Anthem strengthens after upsizing; HeartWare prices, exchanges old bonds
|
5/5/2015 | CV | Market Commentary: LinkedIn slips on hedge; Aegerion down; Cobalt adds; Anthem to price $900 million deal
|
5/5/2015 | CV | Market Commentary: Morning Commentary: LinkedIn slips with weaker shares; Priceline little changed in active trade
|
5/4/2015 | CV | Market Commentary: Morning Commentary: Ares Capital steady after earnings miss; Priceline trades a little higher
|
4/6/2015 | CV | Market Commentary: Convertibles quiet after holiday; SanDisk a little better again; Priceline, Tesla improve
|
3/10/2015 | CVIG | Moody's rates Priceline notes Baa1
|
3/10/2015 | CVIG | S&P assigns Priceline debt BBB+
|
2/24/2015 | CVIG | Moody's rates Priceline notes Baa1
|
2/24/2015 | CVIG | S&P assigns Priceline debt BBB+
|
2/19/2015 | CV | Market Commentary: Health care names weaker after Actavis launches large mandatory; Priceline slightly better
|
2/19/2015 | CV | Market Commentary: Morning Commentary: Priceline jumps; SolarCity drops outright; Actavis offers mandatory
|
2/10/2015 | CV | Market Commentary: Morning Commentary: Upsized Wright Medical pushes up outright, on hedge; old Wright adds again
|
2/6/2015 | CV | Priceline to settle conversion of 1.25% notes in cash starting Feb. 13
|
1/23/2015 | CV | Market Commentary: Priceline active; FXCM better despite lower shares; Array BioPharma surges on drug deal
|
1/23/2015 | CV | Market Commentary: Morning Commentary: Priceline convertibles trade in line; Magnum Hunter Resources gets a glance
|
1/5/2015 | CV | Market Commentary: Convertibles steady as equities sell off; volumes still low; Isis adds with stock on J&J deal
|
1/2/2015 | CV | Market Commentary: Convertibles start new year off on quiet note; weaker shares weigh on market activity
|
12/31/2014 | CV | Outlook 2015: Cheaper pricing, strong issuance eyed after convertibles pull back from 2014 levels
|
12/31/2014 | CV | Market Commentary: Outlook 2015: U.S. convertibles primary notches multi-year high; volume expected to climb
|
12/22/2014 | CV | Market Commentary: Gilead drops in line with shares on Express Scripts news; MGM weaker; recent deals trade
|
12/16/2014 | CV | Market Commentary: Convertibles weaken further amid market turmoil; Lukoil drops; technology names lower
|
12/16/2014 | CV | Market Commentary: Morning Commentary: Convertibles weaken further amid market turmoil; Lukoil drops
|
11/4/2014 | CV | Market Commentary: Slumping oil sends energy names lower; Cobalt, Goodrich down again; LinkedIn to price
|
11/4/2014 | CV | Market Commentary: Morning Commentary: Slumping oil sends energy names lower; Cobalt, Goodrich fall; Priceline down
|
10/10/2014 | CV | Market Commentary: Tech sags after Microchip sales warning; energy names weaken further; new Anacor quiet
|
9/16/2014 | CV | S&P rates Priceline Group debt BBB+
|
9/15/2014 | CV | Market Commentary: Morning Commentary: Convertibles mostly quiet in early trading; Alere gains on stock surge
|
9/11/2014 | CV | Market Commentary: Twitter’s $1.3 billion offering around issue in gray market; WellPoint drops; Tesla slips
|
9/10/2014 | CV | Market Commentary: Many convertibles, including investment grade, weaker; Twitter to price $1.3 billion deal
|
9/10/2014 | CV | Market Commentary: Morning Commentary: Larger issues in action; Priceline, Yahoo slip; Palo Alto gains post earnings
|
9/5/2014 | CV | Market Commentary: New Huron Consulting trades at par; Depomed shares push higher after court decision
|
8/29/2014 | CV | Market Commentary: Convertibles quiet heading into holiday weekend: Priceline 0.9% notes trade slightly lower
|
8/29/2014 | CV | Market Commentary: Morning Commentary: Priceline 0.9% sees buyers, Priceline 1% sellers; Frontline quiet, shares sink
|
8/26/2014 | CV | Market Commentary: Priceline, Illumina trade in line; Medivation, Isis in focus; Prospect Capital bid lower
|
8/26/2014 | CV | Market Commentary: Morning Commentary: Priceline, Illumina in focus, trade in line; Prospect Capital bid lower
|
8/22/2014 | CV | Market Commentary: Salesforce adds on hedge post earnings; Citrix flat; market eyes Jackson Hole comments
|
8/21/2014 | CV | Market Commentary: Convertibles trade quietly, flat on hedge; Priceline unchanged; Photronics shares higher
|
8/21/2014 | CV | Market Commentary: Morning Commentary: Convertibles trade quietly; Priceline flat; Cubist active with shares higher
|
8/20/2014 | CV | Market Commentary: Convertibles see better buyers; Jazz Pharmaceuticals outperforms; Royal Gold holds gains
|
8/19/2014 | CV | Market Commentary: Salix surges on takeout rumors; Illumina paper trades actively; PDL BioPharma in line
|
8/18/2014 | CV | Market Commentary: Gilead Sciences active, trading below parity; Priceline off a bit; USEC convertibles flat
|
8/18/2014 | CV | Market Commentary: Morning Commentary: Priceline off a bit in early trade; Gilead active, less 1.5 points to parity
|
8/15/2014 | CV | Market Commentary: New Priceline slips outright, trades flat on hedge after reoffer; existing Priceline off
|
8/15/2014 | CV | Market Commentary: Morning Commentary: New Priceline convertibles trade around reoffered price of 99
|
8/15/2014 | CV | New Issue: Priceline prices $1 billion 0.9% convertibles due 2020; deal reoffered at 99
|
8/14/2014 | CV | Market Commentary: AOL sees strong debut; planned Priceline seen rich; existing Priceline under pressure
|
8/14/2014 | CV | Market Commentary: Morning Commentary: AOL flat to better on hedge; planned Priceline pressures existing 1% paper
|
8/13/2014 | CV | Market Commentary: Convertibles weaker; Apollo drops with add-on; Ligand, EnerNOC flattish; planned AOL eyed
|
8/13/2014 | CV | Priceline plans up to $1 billion seven-year convertibles to yield 0.75%-0.9%, up 60%
|
8/13/2014 | BKCV | S&P: Priceline notes BBB+
|
8/11/2014 | CV | Market Commentary: Tesla adds on upgrade; Chiquita edges up on takeover offer; Empire State down since issue
|
8/11/2014 | CV | Market Commentary: Morning Commentary: Priceline up slightly with shares; Aegerion selling $250 million convertibles
|
8/4/2014 | BKCV | S&P upgrades Priceline
|
6/17/2014 | CV | Market Commentary: Three deals on tap; Acorda looks slightly cheap; Restoration Hardware looks slightly rich
|